drugset / Trial / NCT02523911

Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening

NCT02523911

RandomizedParallel-groupTriple-blindScreening

Summary

The purpose of this study is to investigate Suprep bowel preparation, with and without the anti-gas medication simethicone, in terms of efficacy and patient tolerability in the preparation of patients undergoing routine colonoscopy for colorectal cancer screening.

Timeline

Start
2016-03
Primary completion
2017-12
Completion
2017-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Simethicone Other / unclassified 2.4 ml Oral
Comparator sodium sulfate/potassium sulfate/magnesium sulfate Unknown 1.6 g Oral
Comparator sodium sulfate/potassium sulfate/magnesium sulfate Unknown 3.13 g Oral
Comparator sodium sulfate/potassium sulfate/magnesium sulfate Unknown 17.5 g Oral

Indications